Both in Pharmaceuticals
DiaMedica Therapeutics vs Ovid Therapeutics
Over the past year DMAC returned +36.0% and OVID returned +84.1%; their daily moves had a correlation of 0.33.
DMAC +36.0% OVID +84.1%Growth of $1, one year, split-adjusted
| Metric | DMAC | OVID |
|---|---|---|
| Price | $9.25 | $2.54 |
| Market cap | $498.8M | $496.1M |
| Today | −2.84% | −0.78% |
| 1 month | +10.8% | +4.5% |
| 6 months | +49.7% | −9.0% |
| Year to date | +16.2% | +55.8% |
| 1 year | +38.3% | +75.2% |
| Revenue growth (YoY) | — | −88.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −2047.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 313.4× |
| Net cash | $43.5M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 53.2% | 57.8% |
| Short % of float | 21.5% | 10.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).